AF-42-MP86_0.1uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=0.1uM, N-(4-{5-[(cyclopropylcarbonyl)amino]-1H-benzimidazol-2-yl}phenyl)cyclopropanecarboxamide (Novartis, 2994523)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/2994523
Similar Terms
Downloads & Tools

Genes

18 genes differentially expressed following the AF-42-MP86_0.1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
ANKK1 ankyrin repeat and kinase domain containing 1 1.43727
APRT adenine phosphoribosyltransferase 0.665379
FBXW5 F-box and WD repeat domain containing 5 0.505676
BUD31 BUD31 homolog (S. cerevisiae) 0.502401
POP5 processing of precursor 5, ribonuclease P/MRP subunit (S. cerevisiae) 0.402262
BAG6 BCL2-associated athanogene 6 0.302883
PPDPF pancreatic progenitor cell differentiation and proliferation factor 0.302883
TNNI3 troponin I type 3 (cardiac) 0.302883
RPS14 ribosomal protein S14 0.302883
LMNA lamin A/C 0.302883
MLF2 myeloid leukemia factor 2 0.2834
NAA10 N(alpha)-acetyltransferase 10, NatA catalytic subunit 0.203073

decreased expression

Symbol Name Standardized Value
RNF34 ring finger protein 34, E3 ubiquitin protein ligase -0.343137
MPLKIP M-phase specific PLK1 interacting protein -0.302883
CREB5 cAMP responsive element binding protein 5 -0.240721
DNPEP aspartyl aminopeptidase -0.210139
ATP5PF ATP synthase peripheral stalk subunit F6 -0.210139
TSPAN3 tetraspanin 3 -0.203591